Search clinical trials

Results for SEARCH ALL

Total 285016 results
Search term:


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 Last


#
NCTID/Status
Study
Last Changed



272053
NCT00113373
Completed
Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer

Conditions: Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
May 3, 2018

272054
NCT00113360
Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Conditions: Neuroendocrine Carcinoma; Islet Cell Carcinoma
August 1, 2012

272055
NCT00113347
Completed
February 23, 2012

272056
NCT00113334
Completed
July 14, 2014

272057
NCT00113321
Terminated
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure

Conditions: Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
August 1, 2012

272058
NCT00113308
Completed
March 13, 2017

272059
NCT00113295
Completed
March 20, 2014


272061
NCT00113269
Completed
August 9, 2011

272062
NCT00113256
Terminated
January 22, 2013

272063
NCT00113243
Unknown status
June 23, 2005

272064
NCT00113230
Completed
July 31, 2012

272065
NCT00113217
Completed
December 2, 2013

272066
NCT00113204
Completed
May 15, 2008

272067
NCT00113191
Completed
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants

Conditions: Nosocomial Infections; Sepsis; Staphylococcal Infections; Candidemia
July 26, 2012

272068
NCT00113178
Completed
February 23, 2011

272069
NCT00113165
Completed
December 2, 2016

272070
NCT00113152
Completed
Heart Disease in Sickle Cell Anemia

Conditions: Sickle Cell Anemia; Pulmonary Hypertension
June 30, 2017

272071
NCT00113139
Completed
July 11, 2014

272072
NCT00113126
Completed
November 28, 2006

272073
NCT00113113
Completed
January 22, 2013

272074
NCT00113100
Completed
Mechanisms of Skin Repair by Topical Estrogen

Conditions: Skin Wrinkling
May 20, 2015

272075
NCT00113087
Completed
September 16, 2010

272076
NCT00113074
Completed
Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers

Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension
January 7, 2013

272077
NCT00113061
Completed
Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults

Conditions: Cardiovascular Diseases; Heart Diseases; Obesity
July 28, 2016

272078
NCT00113048
Terminated
February 4, 2014


272080
NCT00113022
Terminated
Org 24448 to Treat Major Depression

Conditions: Depression
July 9, 2012

272081
NCT00113009
Completed
November 21, 2007

272082
NCT00112996
Completed
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Conditions: Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
April 7, 2014

272083
NCT00112983
Completed
May 29, 2013

272084
NCT00112957
Completed
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Conditions: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
March 15, 2018

272085
NCT00112931
Active, not recruiting
October 24, 2017


272087
NCT00112905
Terminated
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium

Conditions: Adenocarcinoma of the Bladder; Distal Urethral Cancer; Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter; Proximal Urethral Cancer; Recurrent Bladder Cancer; Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter; Recurrent Urethral Cancer; Regional Transitional Cell Cancer of the Renal Pelvis and Ureter; Squamous Cell Carcinoma of the Bladder; Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder; Urethral Cancer Associated With Invasive Bladder Cancer
May 20, 2014

272088
NCT00112892
Completed
Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
January 10, 2014

272089
NCT00112879
Withdrawn
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Conditions: Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
July 9, 2013

272090
NCT00112866
Terminated
Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme

Conditions: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Tumor
May 16, 2017

272091
NCT00112853
Completed
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Conditions: Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia
January 8, 2013

272092
NCT00112840
Completed
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Conditions: Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell Cancer
October 22, 2015

272093
NCT00112827
Active, not recruiting
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Conditions: Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
May 16, 2018


272095
NCT00112749
Terminated
February 12, 2016

272096
NCT00112736
Completed
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Diffuse Astrocytoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Pilocytic Astrocytoma; Adult Pineal Gland Astrocytoma; Adult Subependymal Giant Cell Astrocytoma; Recurrent Adult Brain Tumor
May 29, 2015

272097
NCT00112723
Terminated
Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Splenic Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Waldenström Macroglobulinemia
June 27, 2016



272100
NCT00112684
Terminated
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
February 21, 2014


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 5422 5423 5424 5425 5426 5427 5428 5429 5430 5431 5432 5433 5434 5435 5436 5437 5438 5439 5440 5441 5442 5443 5444 5445 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5682 5683 5684 5685 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 Last




© 2018 ICH GCP